Kaposi's sarcoma-associated herpesvirus can productively infect primary human keratinocytes and alter their growth properties.
about
Primary effect of chemotherapy on the transcription profile of AIDS-related Kaposi's sarcomaMolecular biology of KSHV in relation to AIDS-associated oncogenesis.Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseasesHuman herpesvirus 8 induces polyfunctional B lymphocytes that drive Kaposi's sarcomaKaposi's sarcoma-associated herpesvirus ORF18 and ORF30 are essential for late gene expression during lytic replication.Transcriptional regulation of the K1 gene product of Kaposi's sarcoma-associated herpesvirusHuman viruses and cancer.Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesisNeutral lipid alterations in human herpesvirus 8-infected HUVEC cells and their possible involvement in neo-angiogenesis.Versatility of gene therapy vectors through viruses.Conceptual emergence of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) as an oral herpesvirus.Wild-type Kaposi's sarcoma-associated herpesvirus isolated from the oropharynx of immune-competent individuals has tropism for cultured oral epithelial cells.Telomere/telomerase interplay in virus-driven and virus-independent lymphomagenesis: pathogenic and clinical implications.Kaposi's sarcoma-associated herpesvirus induces the phosphatidylinositol 3-kinase-PKC-zeta-MEK-ERK signaling pathway in target cells early during infection: implications for infectivity.Synergy between Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 Nef protein in promotion of angiogenesis and oncogenesis: role of the AKT signaling pathway.Primary lymphocyte infection models for KSHV and its putative tumorigenesis mechanisms in B cell lymphomas.Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis.Human herpesvirus 8 envelope glycoprotein B mediates cell adhesion via its RGD sequenceThe cytoplasmic terminus of Kaposi's sarcoma-associated herpesvirus glycoprotein B is not essential for virion egress and infectivity.Productive lytic replication of a recombinant Kaposi's sarcoma-associated herpesvirus in efficient primary infection of primary human endothelial cellsHuman herpesvirus 8 infects and replicates in primary cultures of activated B lymphocytes through DC-SIGN.Modulation of host gene expression by the K15 protein of Kaposi's sarcoma-associated herpesvirus.Oral EBV and KSHV infection in HIV.Use of a BJAB-derived cell line for isolation of human herpesvirus 8Kaposi's sarcoma-associated herpesvirus glycoprotein K8.1 is dispensable for virus entry.Raf promotes human herpesvirus-8 (HHV-8/KSHV) infection.Activation of Kaposi's sarcoma-associated herpesvirus lytic gene expression during epithelial differentiation.Infection of primary human tonsillar lymphoid cells by KSHV reveals frequent but abortive infection of T cells.Herpes simplex virus type-1 infection upregulates cellular promoters and telomerase activity in both tumor and nontumor human cells.Expression of DcR3 and its effects in kaposi's sarcoma-associated herpesvirus-infected human endothelial cells.
P2860
Q24802920-113BB7AB-A574-4F4D-BE95-45186D0306F7Q33560572-3B92CDC8-1EE5-47C5-9D1F-00BD03D321F9Q33906970-2BF032C3-C825-493B-B5A1-9DB3BC51B671Q34237804-6B8F700A-7523-4736-AED5-781F9B74359DQ34261905-E05E7922-83C4-460B-9318-34E24C715522Q34351693-8FA780ED-636E-487E-B631-D6387D109EBFQ34423461-A30A73E1-EBDF-4C01-8EAD-68FAEBA5CCA7Q35026060-B526597B-791A-45EF-8A1A-4CD0CAB4735CQ35124404-887E903C-4B96-4EB0-B2CB-D917F9EAF20AQ35607792-E0419470-0600-45B9-8D41-4149EE3CDF41Q36150489-DC8B5234-94E9-45B8-AED8-29C40608A39BQ36467678-F0AB476E-8B01-404F-8A80-794F90873127Q37092875-988C59E7-0451-47A7-9865-C89407A602EBQ37765230-50C07190-36C5-4CF3-9B92-5D068B737636Q38359214-E7C7FA7D-9CBB-49A7-BAA4-1AED0975EA07Q39162945-B4A8AF85-60ED-4050-9E70-A1113E6046F2Q39271443-0D363008-EBA2-4F6E-93DA-C46D7BE2F776Q39683622-0B535793-6F84-4E9C-A7DF-AC1A7AE5841FQ39733480-DCC461AE-E264-4FF6-B2BB-114EEA197958Q39763522-69DE189D-0A56-4952-B154-EE8166CDCD6FQ39996542-4F3CB16F-64CB-46ED-A27B-73CCFBAFEAFEQ40002946-15A06FEC-3D66-40C0-8F7D-8D857344C26DQ40218296-F668EC64-851B-4EB3-81A8-20F7C2CFECD0Q40284107-E30C78D2-AC6F-4E53-B740-AC86924A7168Q40409705-2228D543-BB7D-403D-81E0-D67F92DCEE74Q40551556-F011F5BA-1EB6-4ADE-A44A-949CDDF74534Q40560220-EBB4AB05-EEF3-4A9C-84A7-9F5763476AB1Q42584376-CC7A72EC-140E-493D-9B8D-2708541ED4E7Q42710003-68C2CAAC-3AF6-44ED-8C7E-59FD1294C3C5Q45722354-18122039-B38B-47F0-B527-F9E5C0AB2FE3Q54389394-172F60B5-6460-4690-A4D6-A4173B97E4F6
P2860
Kaposi's sarcoma-associated herpesvirus can productively infect primary human keratinocytes and alter their growth properties.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Kaposi's sarcoma-associated he ...... alter their growth properties.
@en
Kaposi's sarcoma-associated he ...... alter their growth properties.
@nl
type
label
Kaposi's sarcoma-associated he ...... alter their growth properties.
@en
Kaposi's sarcoma-associated he ...... alter their growth properties.
@nl
prefLabel
Kaposi's sarcoma-associated he ...... alter their growth properties.
@en
Kaposi's sarcoma-associated he ...... alter their growth properties.
@nl
P2093
P2860
P1433
P1476
Kaposi's sarcoma-associated he ...... alter their growth properties.
@en
P2093
P2860
P304
P356
10.1128/JVI.75.5.2435-2443.2001
P407
P577
2001-03-01T00:00:00Z